Salus IRB provides review of proposed research to determine if a project is exempt from IRB review (i.e., research activities in which the only involvement of human subjects falls within one or more of the categories outlined at 45 CFR 46.104(d)).
If the board determines your research to be exempt, Salus requires submission of any modification to the research for prospective review and determination of continued exemption status prior to the implementation of the change. In some circumstances, changes to the protocol may disqualify the research from exempt status. A written notification to Salus that the research is completed or terminated is also required within 30 days of completion or termination of all research activity.
To determine if your research is exempt from IRB review, refer to Salus Form 100.D Supplemental for Exempt Research.
For more information, contact Client Services.